Keywords: Elan, Biogen, multiple sclerosis, Tysabri

Elan in dispute with Biogen over Tysabri

Article | 07 August 2009

Print This

Irish drugmaker Elan Corporation has filed suit against USA-based Biogen Idec in Federal Court in New York seeking declaratory and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in